Shimatsu Y
Department of Medicine (II), Niigata University Medical School.
Kansenshogaku Zasshi. 1991 Mar;65(3):326-35. doi: 10.11150/kansenshogakuzasshi1970.65.326.
To elucidate the phagocytic activity of polymorphonuclear leukocytes (PMN) in systemic lupus erythematosus (SLE), we assayed the luminol dependent chemiluminescence of PMN (PMN-CL) of 30 patients with SLE, and evaluated the effects of disease activities and corticosteroid (steroid) therapy on the PMN-CL. The PMN-CL of active SLE patients (n = 10) before steroid therapy increased significantly compared to normal controls when stimulated with phorbol myristate acetate (PMA) (p less than 0.05). On the contrary it decreased significantly when stimulated with opsonized zymosan (OZ) (p less than 0.01). The PMN-CL of SLE patients under steroid therapy (average prednisolone dose, 40.4 mg/day) revealed a tendency to decrease according to the increase of total steroid dose. It was correlated with the total steroid dose for the preceding 12 or 16 weeks, when stimulated with formyl-methionylleucyl-phenylalanine and PMA. However it was not related with the current steroid dose. Thus the increase of PMN-CL by PMA stimulation as well as the decrease by OZ stimulation seems to be a characteristic phenomenon in SLE. The PMN phagocytic activity in SLE will be suppressed after more than 12 weeks therapy of large doses of steroid.
为阐明系统性红斑狼疮(SLE)患者多形核白细胞(PMN)的吞噬活性,我们检测了30例SLE患者PMN的鲁米诺依赖性化学发光(PMN-CL),并评估了疾病活动度和皮质类固醇(激素)治疗对PMN-CL的影响。与正常对照组相比,活动期SLE患者(n = 10)在接受激素治疗前,用佛波酯(PMA)刺激时PMN-CL显著增加(p < 0.05)。相反,用调理酵母聚糖(OZ)刺激时PMN-CL显著降低(p < 0.01)。接受激素治疗的SLE患者(泼尼松龙平均剂量,40.4 mg/天)的PMN-CL显示出随着总激素剂量增加而降低的趋势。在用甲酰甲硫氨酰亮氨酰苯丙氨酸和PMA刺激时,它与前12周或16周的总激素剂量相关。然而,它与当前激素剂量无关。因此,PMA刺激导致PMN-CL增加以及OZ刺激导致PMN-CL降低似乎是SLE的特征性现象。大剂量激素治疗超过12周后,SLE患者的PMN吞噬活性将受到抑制。